Publications by authors named "Rachel Schiff"

Claim this Profile
W
What Predicts Listening Comprehension in Standard Arabic? The Interdependence of Linguistic and Metalinguistic Skills in Spoken and Standard Arabic.
Lina Haj, Elinor Saiegh-Haddad, Ola Ghawi-Dakwar, Rachel Schiff

J Speech Lang Hear Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA.
Heather A Parsons, Conor Messer, Katheryn Santos, Jakob Weiss, David Merrell, Rachel Schiff

Cell Genom· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceramide-induced Endoplasmic Reticulum Stress as a Targetable Vulnerability in Endocrine Therapy-Resistant Breast Cancer.
Purab Pal, Shweta Chitkara, Godwin K Sarpey, Fatimah Alani, Huiping Zhao, Rachel Schiff

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial.
Christian Maurer, Elisa Agostinetto, Lieveke Ameye, Matteo Lambertini, Samuel Martel, Rachel Schiff

Breast Cancer Res Treat· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines.
Ilenia Migliaccio, Martina Bonechi, Dario Romagnoli, Giulia Boccalini, Francesca Galardi, Rachel Schiff

NPJ Breast Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2-positive breast cancer.
Noor Mazin Abdulkareem, Raksha Bhat, Micah Castillo, Sung Yun Jung, Suhas Vasaikar, Rachel Schiff

Br J Pharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-Positive Breast Cancer Treatment and Resistance.
Jamunarani Veeraraghavan, Carmine De Angelis, Carolina Gutierrez, Fu-Tien Liao, Caroline Sabotta, Rachel Schiff

Adv Exp Med Biol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.
Anran Chen, Beom-Jun Kim, Aparna Mitra, Craig T Vollert, Jonathan T Lei, Rachel Schiff

Mol Cancer Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.
Cristina Guarducci, Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Heraud, Rachel Schiff

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.
Jamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, Robert Davis, Tao Wang, Rachel Schiff

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer.
Xiaoyong Fu, Resel Pereira, Chia-Chia Liu, Carmine De Angelis, Martin J Shea, Rachel Schiff

Cell Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can adults with developmental dyslexia apply statistical knowledge to a new context?
Rachel Schiff, Hadar Cohen, Shani Kahta, Ayelet Sasson

Cogn Process· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elacestrant and the Promise of Oral SERDs.
Katherine G Sanchez, Julie R Nangia, Rachel Schiff, Mothaffar F Rimawi

J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.
Agostina Nardone, Xintao Qiu, Sandor Spisak, Zsuzsanna Nagy, Ariel Feiglin, Rachel Schiff

Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells.
Purab Pal, Alec Millner, Svetlana E Semina, Rosemary J Huggins, Logan Running, Rachel Schiff

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial grammar learning is facilitated by distributed practice: Evidence from a letter reordering task.
Rachel Schiff, Ayelet Sasson, Hadas Green, Shani Kahta

Cogn Process· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer.
Raksha Bhat, Hariprasad Thangavel, Noor Mazin Abdulkareem, Suhas Vasaikar, Carmine De Angelis, Rachel Schiff

Sci Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic.
Xiaoyong Fu, Carmine De Angelis, Rachel Schiff

Endocrinology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancer.
Jason A Mouabbi, C Kent Osborne, Rachel Schiff, Mothaffar F Rimawi

Breast Cancer Res Treat· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoring order at the cell cycle border: Co-targeting CDK4/6 and CDK2.
Rinath Jeselsohn, Rachel Schiff, Albert Grinshpun

Cancer Cell· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.
Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Rachel Schiff

Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer.
Noor Mazin Abdulkareem, Raksha Bhat, Lanfang Qin, Suhas Vasaikar, Ambily Gopinathan, Rachel Schiff

FASEB J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models.
Jamunarani Veeraraghavan, Carolina Gutierrez, Vidyalakshmi Sethunath, Sepideh Mehravaran, Mario Giuliano, Rachel Schiff

NPJ Breast Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bone microenvironment increases phenotypic plasticity of ER breast cancer cells.
Igor L Bado, Weijie Zhang, Jingyuan Hu, Zhan Xu, Hai Wang, Rachel Schiff

Dev Cell· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis.
Francesco Schettini, Mario Giuliano, Fabiola Giudici, Benedetta Conte, Pietro De Placido, Rachel Schiff

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis